Shares of Divis Laboratories today surged almost 9 per cent after the drug firm reported 45 per cent rise in net profit for the June quarter.
The stock gained 8 per cent to Rs 2,129.90 — its 52-week high — at the BSE.
At the NSE, it went up 8.86 per cent to touch its one-year high of Rs 2,145.
Divis Laboratories on Saturday reported 45 per cent rise in net profit at Rs 243.18 crore for the June quarter, from Rs 167.93 crore a year ago.
Net sales of the company rose to Rs 806.91 crore for the first quarter as against Rs 639.76 crore in the year-ago quarter, Divis Laboratories had said in a filing to BSE.
“Forex translation gain for the current quarter amounted to Rs 21 crore as against a gain of Rs 1 crore during the corresponding quarter of last year,” it added.
The company’s board has recommended bonus shares in the ratio of 1:1.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.